Alessandro Amaddeo

Prof. Alessandro Amaddeo

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016 in The Lancet Respiratory Medicine
Verified
Journal Article
Closed access
AAAlessandro Amaddeo
Alessandro Amaddeo
AFAnnick Frapin
Annick Frapin
BFBrigitte Fauroux
Brigitte Fauroux

1 April 2011 in Breastfeeding Medicine
Verified
Journal Article
Closed access
RDRiccardo Davanzo
Riccardo Davanzo
MCMarco Copertino
Marco Copertino
ACAngela De Cunto
Angela De Cunto
FMFederico Minen
Federico Minen
AAAlessandro Amaddeo
Alessandro Amaddeo
The use of antidepressants in breastfeeding mothers is controversial: Manufacters often routinely discourage breastfeeding for the nursing mother despite the well-known positive impact that breastfeeding carries on the health of the nursing infant and on his or her family and society. We conducted a systematic review of drugs commonly used in the treatment of postpartum depression. For every single drug two sets of data were provided: (1) selected pharmacokinetic characteristics such as half-life, milk-to-plasma ratio, protein binding, and oral bioavailability and (2) information about lactational risk, according to some authoritative sources of the literature: Drugs in Pregnancy and Lactation edited by Briggs et al. (Lippincott Williams, Philadelphia, 2008), Medications and Mothers' Milk by Hale (Hale Publishing, Amarillo, TX, 2010), and the LactMed database of TOXNET (www.pubmed.gov; accessed June 2010). Notwithstanding a certain variability of advice, we found that (1) knowledge of pharmacokinetic characteristics are scarcely useful to assess safety and (2) the majority of antidepressants are not usually contraindicated: (a) Selective serotinin reuptake inhibitors and nortryptiline have a better safety profile during lactation, (b) fluoxetine must be used carefully, (c) the tricyclic doxepine and the atypical nefazodone should better be avoided, and (d) lithium, usually considered as contraindicated, has been recently rehabilitated.

27 February 2017 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
RTRossana Tenconi
Rossana Tenconi
SKSonia Khirani
Sonia Khirani
AAAlessandro Amaddeo
Alessandro Amaddeo
CMCaroline Michot
Caroline Michot
GBGeneviève Baujat
Geneviève Baujat
BFBrigitte Fauroux
Brigitte Fauroux

25 April 2016 in Pediatric Pulmonology
Verified
Journal Article
Closed access
PDF file
AAAlessandro Amaddeo
Alessandro Amaddeo
JMJ. Moreau
J. Moreau
AFA. Frapin
A. Frapin
SKS. Khirani
S. Khirani
OFO. Felix
O. Felix
BFB. Fauroux
B. Fauroux

1 February 2016 in Plastic and Reconstructive Surgery
Verified
Journal Article
Closed access
AAAlessandro Amaddeo
Alessandro Amaddeo
VAVeronique Abadie
Veronique Abadie
CCChristel Chalouhi
Christel Chalouhi
NKNatacha Kadlub
Natacha Kadlub
AFAnnick Frapin
Annick Frapin
BFBrigitte Fauroux
Brigitte Fauroux
The aim of the study was to evaluate noninvasive continuous positive airway pressure as first-line treatment for upper airway obstruction in neonates with Pierre Robin sequence. Forty-four neonates were enrolled and classified in 4 groups: ventilator-dependent patients (severe upper airway obstruction group), patients with clinical upper airway obstruction, an abnormal (moderate upper airway obstruction group) or normal polygraphy (mild upper airway obstruction group), and those with no clinical upper airway obstruction (no upper airway obstruction group). Five neonates in the severe upper airway obstruction group (n = 9) were successfully managed by noninvasive continuous positive airway pressure and 4 required a tracheotomy. The moderate upper airway obstruction group (n = 4) was successfully managed by noninvasive continuous positive airway pressure and the other patients by prone positioning. Continuous positive airway pressure represents an effective treatment of upper airway obstruction in Pierre Robin sequence and may be recommended in selected patients. Therapeutic, IV.

1 September 2016 in Sleep Medicine
Verified
Journal Article
Closed access
OFOrlane Felix
Orlane Felix
AAAlessandro Amaddeo
Alessandro Amaddeo
JAJorge Olmo Arroyo
Jorge Olmo Arroyo
MZMichel Zerah
Michel Zerah
SPStephanie Puget
Stephanie Puget
BFBrigitte Fauroux
Brigitte Fauroux